–
FibroBiologics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
−4.07
FY23:
−6.40
FY24:
−11.9
FY25:
−16.4
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−0.50
FY24:
−0.18
FY25:
−0.26
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
5.93
FY23:
13.8
FY24:
16.9
FY25:
7.57
millions USD
FY21:
–
FY22:
1.86
FY23:
6.90
FY24:
4.82
FY25:
−9.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.41
FY22:
–
FY23:
−6.90
FY24:
−12.1
FY25:
−16.7
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.